---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-26-004806"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2026-04-17T23:59:59+00:00"
generated_at: "2026-05-15T05:32:06.325316+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro annual meeting: all proposals pass, including reverse stock split up to 1:10

## Summary
- All seven director nominees elected, including William B. Horne, Milton C. Ault III, Stephan Jackman, Henry C. Nisser, Mark Gustafson, Lynne F. McGrath, Jeffrey Oram.
- Shareholders approved reverse stock split (Proposal 6): ratio 1:2 to 1:10, board discretion, before April 16, 2027. Vote: 1,150,722 for, 445,185 against.
- Ratification of Haskell & White LLP as independent auditor (Proposal 2): 1,454,276 for, 114,748 against, no broker non-votes.
- Advisory vote on executive compensation (Proposal 3) passed: 276,241 for, 124,274 against, with 1,185,412 broker non-votes.
- 2025 Stock Incentive Plan (Proposal 4) and equity issuance approval (Proposal 5) also passed.

## SEC filing metadata
- accession: 0001214659-26-004806
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2026-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465926004806/0001214659-26-004806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465926004806/p4172668k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-26-004806
- JSON: https://secwatch.observer/filing/0001214659-26-004806.json
- Plain text: https://secwatch.observer/filing/0001214659-26-004806.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.